Benjamin Edwards Inc. Purchases 105,196 Shares of Colgate-Palmolive (NYSE:CL)

Benjamin Edwards Inc. boosted its position in Colgate-Palmolive (NYSE:CL) by 10,946.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 106,157 shares of the company’s stock after acquiring an additional 105,196 shares during the period. Benjamin Edwards Inc.’s holdings in Colgate-Palmolive were worth $11,020,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CL. EverSource Wealth Advisors LLC increased its holdings in Colgate-Palmolive by 10.0% in the first quarter. EverSource Wealth Advisors LLC now owns 1,950 shares of the company’s stock valued at $179,000 after purchasing an additional 177 shares during the last quarter. Mather Group LLC. boosted its position in shares of Colgate-Palmolive by 33.4% during the second quarter. Mather Group LLC. now owns 8,968 shares of the company’s stock worth $808,000 after purchasing an additional 2,245 shares in the last quarter. Fulton Bank N.A. grew its holdings in shares of Colgate-Palmolive by 4.2% in the 2nd quarter. Fulton Bank N.A. now owns 5,529 shares of the company’s stock valued at $537,000 after buying an additional 222 shares during the period. Kingswood Wealth Advisors LLC increased its position in shares of Colgate-Palmolive by 3.7% in the 2nd quarter. Kingswood Wealth Advisors LLC now owns 14,081 shares of the company’s stock valued at $1,366,000 after buying an additional 496 shares in the last quarter. Finally, Park Avenue Securities LLC raised its stake in Colgate-Palmolive by 5.0% during the 2nd quarter. Park Avenue Securities LLC now owns 7,739 shares of the company’s stock worth $751,000 after buying an additional 371 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Up 0.5 %

CL stock opened at $97.10 on Tuesday. The company has a market cap of $79.33 billion, a price-to-earnings ratio of 27.82, a P/E/G ratio of 3.45 and a beta of 0.42. Colgate-Palmolive has a twelve month low of $75.50 and a twelve month high of $109.30. The business has a 50 day moving average price of $97.38 and a two-hundred day moving average price of $98.64. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a $0.50 dividend. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 annualized dividend and a dividend yield of 2.06%. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Insider Buying and Selling

In related news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.34% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. TD Cowen decreased their target price on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a research note on Monday, October 28th. Piper Sandler initiated coverage on Colgate-Palmolive in a research report on Tuesday, September 24th. They issued an “overweight” rating and a $121.00 price objective for the company. Wells Fargo & Company dropped their target price on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a report on Monday, October 28th. Stifel Nicolaus cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and reduced their price target for the company from $105.00 to $101.00 in a report on Monday, October 28th. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and raised their price objective for the stock from $107.00 to $109.00 in a report on Monday, September 9th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $105.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.